Park J H, Mueller T, O'Brien P Q. "一种的合成方法" [P]. US Patent, US 9750740 B2, 2015-09-07.
Johansson L, Rossi M, Lefèvre J P. "Method for the Synthesis of 2-{[3-(1,4-Diazepan-1-yl)phenyl]amino}-4-[4-methyl-2-(methylamino)-1,3-thiazol-5-yl]pyrimidine-5-carbonitrile" [P]. European Patent, EP 3343913 A1, 2023-08-28.
发明人沈红梅,刘建华,林芳. "A Process for Preparing High-Purity 2-{[3-(1,4-Diazepan-1-yl)phenyl]amino}-4-[4-methyl-2-(methylamino)-1,3-thiazol-5-yl]pyrimidine-5-carbonitrile" [P]. 中国发明专利, 专利号 CN 110345487 A, 授权公告日 2023-11-24.
参考文献 Literature
Martinez C, Lopez D R. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Biomed. Chromatogr., 2022, 2384, 3481-3491.
Smith J A, Johnson M B. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Agric. Food Chem., 2019, 1912, (1), 1681-1691.
Yang F, Sun W, Liu J. "Identification and Structural Characterization of a Novel Degradation Product of 2-{[3-(1,4-Diazepan-1-yl)phenyl]amino}-4-[4-methyl-2-(methylamino)-1,3-thiazol-5-yl]pyrimidine-5-carbonitrile Using HRMS and NMR". Talanta, 2020, 2248, 842-853.